It is a pharma private limited company based in Vadodara, Gujarat, India, established in 2018.
2018 | Vadodara, Gujarat, India | ActiveCraton Pharmaceuticals Private Limited, a active private limited company, was established on 28 November 2018 in Vadodara, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239GJ2018PTC105361. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Gaurav Girishchandra Pandya (Director), Nishith Dilipbhai Pathak (Director), Arpitaben Amitkumar Patel (Director). Past directors included Amitkumar Ashokbhai Patel, Sunil Jagdishlal Brahamkhatri, Hiteshbhai Nareshbhai Makani. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at F-46, Marutidham Duplex, Near Sugam Society, Harni Road,, Vadodara, Gujarat, 390022.
U24239GJ2018PTC105361
105361
28 November 2018
₹0.10 M
₹0.10 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Craton Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gaurav Girishchandra Pandya | Director | 20 Nov 2021 | Current |
| Nishith Dilipbhai Pathak | Director | 20 Nov 2021 | Current |
| Arpitaben Amitkumar Patel | Director | 20 Nov 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 14 Dec 2021 | Past |
| Pramod Abcsdd | Director | 14 Dec 2021 | Past |
| Pramod Abcsdd | Director | 14 Dec 2021 | Past |
| Pramod Abcsdd | Director | 04 Jun 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Craton Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 6973.67% increase. The company also saw a substantial fall in profitability, with a 1203.33% decrease in profit. The company's net worth observed a substantial decline by a decrease of 28.94%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Craton Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Craton Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Craton Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Craton Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Craton Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was documented.
The activity Gaurav Girishchandra Pandya was appointed as a Director was appointed as a Director on 20 Nov 2021 & has been associated with this company since 4 years 28 days . was completed.
Progress on Nishith Dilipbhai Pathak was appointed as a Director was appointed as a Director on 20 Nov 2021 & has been associated with this company since 4 years 28 days . was documented.
Progress on Arpitaben Amitkumar Patel was appointed as a Director was appointed as a Director on 20 Nov 2021 & has been associated with this company since 4 years 28 days . was documented.
Progress on Craton Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Ahmedabad. was documented.
The activity Craton Pharmaceuticals Private Limited was registered on 28 Nov 2018 with Roc Ahmedabad & aged 7 years 21 days as per MCA records. was completed.
The CIN of Craton Pharmaceuticals Private Limited is U24239GJ2018PTC105361.
Craton Pharmaceuticals Private Limited is headquartered at F-46, Marutidham Duplex, Near Sugam Society, Harni Road,, Vadodara, Gujarat, 390022.
Craton Pharmaceuticals Private Limited was incorporated on 28 November 2018.
The current directors of Craton Pharmaceuticals Private Limited are
The primary industry of Craton Pharmaceuticals Private Limited is Manufacturing.
Craton Pharmaceuticals Private Limited is unlisted.
The authorized capital of Craton Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX